Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum
- PMID: 2848083
Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum
Abstract
The neutrophil myeloperoxidase-H2O2-halide enzyme system produces hypochlorous acid and chlorinated amine compounds capable of killing a variety of target cells. In the present study we hypothesized that the myeloperoxidase enzyme system is one mechanism for airway epithelial damage in patients with cystic fibrosis (CF). Enzyme linked immunosorbent assay detected high antigenic levels of myeloperoxidase in sputum samples of seven patients with CF. Myeloperoxidase was purified to homogeneity from CF sputum and from blood neutrophils by a three-step technique involving dialysis, gel filtration, and ion-exchange chromatography. CF sputum myeloperoxidase and neutrophil myeloperoxidase appeared identical by acid gel electrophoresis and Ouchterlony experiments. CF sputum myeloperoxidase also contained approximately the same enzymatic activity as neutrophil myeloperoxidase. The myeloperoxidase enzyme system was tested for its cytotoxic potential in a tracheal ring culture system. Myeloperoxidase-induced cytotoxicity for airway epithelium was confirmed by light microscopy and radiolabelling experiments. These findings suggest a possible role for neutrophil myeloperoxidase in CF lung disease.
Similar articles
-
Neutrophil collagenase in sputum from patients with cystic fibrosis.Am J Respir Crit Care Med. 1994 Sep;150(3):818-22. doi: 10.1164/ajrccm.150.3.8087357. Am J Respir Crit Care Med. 1994. PMID: 8087357
-
Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1).PLoS One. 2017 Jan 30;12(1):e0170203. doi: 10.1371/journal.pone.0170203. eCollection 2017. PLoS One. 2017. PMID: 28135312 Free PMC article.
-
Proteinase-free myeloperoxidase increases airway epithelial permeability in a whole trachea model.Pediatr Pulmonol. 1997 Jul;24(1):29-34. doi: 10.1002/(sici)1099-0496(199707)24:1<29::aid-ppul5>3.0.co;2-e. Pediatr Pulmonol. 1997. PMID: 9261850
-
The role of bacterial proteases in the pathogenesis of cystic fibrosis.Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 2):S118-22. doi: 10.1164/ajrccm/150.6_Pt_2.S118. Am J Respir Crit Care Med. 1994. PMID: 7952646 Review.
-
Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.Semin Respir Infect. 1992 Sep;7(3):168-78. Semin Respir Infect. 1992. PMID: 1475541 Review.
Cited by
-
Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.Free Radic Res. 2011 Feb;45(2):165-76. doi: 10.3109/10715762.2010.521154. Epub 2010 Oct 18. Free Radic Res. 2011. PMID: 20954832 Free PMC article.
-
Inhibitory effect of erythromycin on superoxide anion production by human neutrophils primed with granulocyte-colony stimulating factor.Antimicrob Agents Chemother. 1998 Jul;42(7):1866-7. doi: 10.1128/AAC.42.7.1866. Antimicrob Agents Chemother. 1998. PMID: 9661038 Free PMC article. No abstract available.
-
Protease cleavage of iron-transferrin augments pyocyanin-mediated endothelial cell injury via promotion of hydroxyl radical formation.Infect Immun. 1996 Jan;64(1):182-8. doi: 10.1128/iai.64.1.182-188.1996. Infect Immun. 1996. PMID: 8557338 Free PMC article.
-
Eosinophilic activation in cystic fibrosis.Thorax. 1994 May;49(5):496-9. doi: 10.1136/thx.49.5.496. Thorax. 1994. PMID: 8016773 Free PMC article.
-
Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation.J Clin Invest. 1991 Oct;88(4):1092-102. doi: 10.1172/JCI115408. J Clin Invest. 1991. PMID: 1655825 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials